Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story?
Taddei
Stefano
S
Ghiadoni
Lorenzo
L
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000187:drug effects*; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human